AstraZeneca's (LON:AZN) "Buy" Rating Reiterated at Citigroup

Cornelia Mascio
Marzo 15, 2018

The Brandes Investment Partners Lp holds 241,197 shares with $8.17M value, up from 231,588 last quarter. AstraZeneca plc has a one year low of $28.43 and a one year high of $36.70.

AstraZeneca (LON AZN) traded up GBX 14.50 ($0.20) during trading on Monday, reaching GBX 4,800 ($66.32). About 2.30M shares traded. AstraZeneca PLC (NYSE:AZN) has risen 19.45% since March 13, 2017 and is uptrending. It has outperformed by 2.75% the S&P500.

Bowling Portfolio Management Llc decreased Eplus Inc (PLUS) stake by 26.2% reported in 2017Q3 SEC filing. Russell Investments Group Ltd. now owns 1,856,140 shares of the company's stock worth $62,883,000 after acquiring an additional 1,235,239 shares during the last quarter. The SI to Hubbell Inc's float is 1.41%. The stock decreased 0.10% or $0.025 during the last trading session, reaching $25.985. About 967,380 shares traded. (NYSE:HTA) has risen 7.80% since March 14, 2017 and is uptrending. It has outperformed by 58.96% the S&P500.

Among 26 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 16 have Buy rating, 0 Sell and 10 Hold. The rating was maintained by Stifel Nicolaus with "Hold" on Thursday, August 3. (NYSE:HTA) has "Buy" rating given on Thursday, December 31 by Stifel Nicolaus. JPMorgan Chase & Co. raised shares of AstraZeneca from a neutral rating to an overweight rating in a research note on Friday, December 29th. On Thursday, November 5 the stock rating was maintained by Canaccord Genuity with "Buy". Jefferies maintained the stock with "Buy" rating in Friday, July 7 report. The firm has "Strong Buy" rating given on Monday, July 17 by Raymond James. The brokerage now has a neutral rating on the biopharmaceutical company's stock. Leerink Swann maintained it with "Market Perform" rating and $34 target in Monday, May 2 report.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.07, from 0.89 in 2017Q2. It increased, as 69 investors sold LUV shares while 249 reduced holdings.

A number of hedge funds have recently made changes to their positions in the business. Bessemer Group holds 13,700 shares. 20,998 are held by Clarivest Asset Limited Company. Art Advsr Ltd Llc holds 0.03% of its portfolio in ePlus inc. (NASDAQ:PLUS) for 6,168 shares. Group Inc Inc owns 0% invested in ePlus inc. (NASDAQ:PLUS) for 10,527 shares. Comml Bank Of America Corp De reported 12,655 shares stake. (NASDAQ:PLUS). Principal Gp invested in 113,877 shares. The Illinois-based Chicago Equity Prns Ltd Limited Liability Company has invested 0.31% in ePlus inc. The New York-based Metropolitan Life Ins Company has invested 0.01% in ePlus inc.

Analysts await ePlus inc. (NYSE:HTA) to report earnings on April, 25. They expect $0.44 EPS, down 55.56% or $0.55 from last year's $0.99 per share. AZN's profit will be $1.10 billion for 19.32 P/E if the $0.44 EPS becomes a reality. After $1.30 actual EPS reported by AstraZeneca PLC for the previous quarter, Wall Street now forecasts -66.15% negative EPS growth.

Since October 17, 2017, it had 1 buy, and 8 insider sales for $7.20 million activity. BOWEN BRUCE M had sold 9,600 shares worth $804,173. MARRON MARK P also sold $1.35M worth of ePlus inc. Shareholders of record on Thursday, February 15th will be issued a GBX 133.60 ($1.85) dividend. It also upped Schwab U.S. Large (SCHX) stake by 6,937 shares and now owns 209,851 shares.

Equus Total Return Inc (NYSE:EQS) had an increase of 184.21% in short interest.

Glenmede Trust Company Na decreased Schlumberger (NYSE:SLB) stake by 44,564 shares to 1.08M valued at $75.31 million in 2017Q3. Toyota Motor Corp (NYSE:TM) was reduced too.

The stock rating of AstraZeneca PLC (LON:AZN) was restate by professional analysts at Shore Capital. Therefore 62% are positive. AstraZeneca PLC had 616 analyst reports since July 23, 2015 according to SRatingsIntel. Bernstein maintained AstraZeneca PLC (LON:AZN) rating on Tuesday, November 24. Finally, Sanford C. Bernstein boosted their target price on AstraZeneca from $40.00 to $42.00 and gave the stock an "outperform" rating in a research note on Monday, February 5th. Jefferies downgraded the shares of AZN in report on Monday, April 10 to "Hold" rating. The rating was maintained by Cowen & Co on Monday, October 16 with "Hold". The firm has "Neutral" rating by Credit Suisse given on Friday, May 12. The firm earned "Overweight" rating on Tuesday, December 1 by Morgan Stanley.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE